| Net (loss) income | -1.69M |
| Depreciation and amortization | 1.6M |
| Provision for bad debts | 0 |
| Share of net loss from investment under equity method | |
| Loss on sale of assets | |
| Stock issued for interest on notes payable | |
| Stock issued for services | 21.8K |
| Fair market value of warrants and stock options granted | |
| Beneficial conversion feature | |
| Increase/ decrease in accounts receivable | 2.34M |
| Increase/ decrease in other current assets | |
| Increase/ decrease in accounts payable and accrued expenses | -780.57K |
| Net cash provided by (used in) operating activities | -217.53K |
| Purchases of property and equipment | -554.87K |
| Sales of property and equipment | 151.82K |
| Purchase of non-controlling interest in subsidiary | |
| Short-term investments held for sale | |
| Investment under equity method | |
| Increase in intangible assets | |
| Net cash used in investing activities | -958.61K |
| Proceeds from sale of common stock | |
| Proceeds from the exercise of stock options and warrants | 14.01K |
| Proceeds from convertible notes payable | |
| Payments on convertible notes payable | |
| Restricted cash | |
| Bank overdraft | |
| Proceeds from bank loans | 0 |
| Payments on bank loans | |
| Payments on capital lease obligations & loans - net | -49.12K |
| Net cash provided by financing activities | 241.76K |
| Effect of exchange rate changes in cash | 533.29K |
| Net increase in cash and cash equivalents | -401.09K |
| Cash and cash equivalents, beginning of year | 11.56M |
| Cash and cash equivalents, end of year | 11.16M |
| Interest | 83.67K |
| Taxes | |
| Stock issued for the conversion of Notes Payable | |